Ergoteles’s Blend Labs BLND Stock Holding History

Ergoteles’s Portfolio BLND Stock Details BLND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-187,200	Closed	-$177K	–	136
2023 Q2	$177K	Buy	187,200 +52,730	+39%	+$46.7K	0.01%	865
2023 Q1	$134K	Sell	134,470 -121,935	-48%	-$187K	0.01%	1076
2022 Q4	$369K	Buy	+256,405	New	+$460K	0.01%	832

Other funds holding BLND

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

LUGPI

Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Greylock 15 Menlo Park, California $85.6M AUM 199.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ShawSpring Partners Boston, Massachusetts $268M AUM 28.19% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Metavasi Capital Larchmont, New York $276M AUM 92.83% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ergoteles's BLND Position: Q3 2023 in Review

Ergoteles sold out of Blend Labs (BLND) in Q3 2023, closing a stake of 187,200 shares — an estimated $177K sold.

Ergoteles first reported a position in BLND in Q4 2022 and held it in 3 quarters. The position peaked at $369K in Q4 2022. 85 funds tracked by Wall St. Rank hold BLND as of Q3 2023.

Ergoteles reported no remaining Blend Labs position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 187,200 Blend Labs shares in Q3 2023, an estimated $177K.
Ergoteles first reported a position in Blend Labs in Q4 2022 and held it in 3 quarters.
Ergoteles's Blend Labs position peaked at $369K in Q4 2022.
85 funds tracked by Wall St. Rank held Blend Labs as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.